Keywords: APC; antigen-presenting cell; BMT; bone marrow transplantation; CKBMT; combined kidney and bone marrow transplantation; CML; cell-mediated lympholysis; DLI; donor leukocyte infusions; GVHD; graft-vs-host disease; GVL; graft-vs-leukemia/lymphoma; LDA; limi
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Lignin; NaDES; GVL; Ultrasound; Microwaves; Antioxidant activity;
Keywords: GvL; graft versus leukemia/lymphoma; HSCT; hematopoietic stem cell transplantation; CNS; central nervous system; ALL; acute lymphoblastic leukemia; CSF; cerebrospinal fluid; STR; short tandem repeat; Hematopoietic stem cell transplantation; Donor chimeris
Keywords: GVL; γ-valerolactone; RB; Residual Biomass; PSSF; Pre-hydrolysis simultaneous saccharification and fermentation; NP; Nonylpheol; RSM; Response surface methodology; NS; Non-significant; CR; Cellulose recovery %; Organosolv pretreatment; Eucalyptus; Gamma-
Keywords: Meso-MOFs; mesoporous metal-organic frameworks; PCNs; porous coordination networks; SBU; secondary building unit; CUSs; coordinatively unsaturated sites; H2BDC; 1,4-benzene dicarboxylic acid (terephthalic acid); H3BTC; 1,3,5-benzene tricarboxylic acid (
Keywords: NK; natural killer; AI; adoptive immunotherapy; HSCT; hematopoietic stem cell transplant; GVL; graft versus leukemia; GVHD; graft-versus-host disease; PB; peripheral blood; IFN; interferon; KIR; killer immunoglobulin-like receptor; AML; acute myeloid leuk
Keywords: 3-HPA; 3-hydroxypropionic acid; AD; anaerobic digestion; AHA; α-hydroxy acid; AX; arabinoxylans; BM; biomethane; BS; biosyngas; CAGR; compounded annual growth rate; CHP; combined heat and power; CMF; 5-chloromethyl furfural; DHA; docosahexanoid acid; DME
Keywords: Lignocellulosic pretreatment; Cellulose; Lignin; Sugar; Pulp; Bioproducts; AFEX; Ammonia fibre expansion; FDCA; 2,5-furandicarboxylic acid; GVL; γ-valerolactone; HMF; 5-hydroxymethyl; SPORL; sulfite pretreatment to overcome recalcitrance of lignocellulos
Keywords: Chronic lymphocytic leukemia; Allogeneic hematopoietic stem cell transplantation; Novel substances; High-risk patients; GvL; GvHD;
Potential advantages of CD1-restricted T cell immunotherapy in cancer
Keywords: ACT; adoptive cell therapy; MHC; major histocompatibility complex; TCR; T cell receptor; TIL; tumor-infiltrating lymphocyte; TAA; tumor-associated antigen; APC; antigen-presenting cell; DC; dendritic cell; HSCT; hematopoietic stem cell transplantation; Gv
Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells
Keywords: adoptive transfer; allo-reactivity; automation; CliniMACS Prodigy; GVL; GVHD; immunomagnetic; selection; technology;
HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor
Keywords: ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; ATG; anti-thymocyte globulin; BM; bone marrow; CBA; coalescent-based analysis; CI; confidence interval; CML/CLL; chronic leukemia, CMV, cytomegalovirus; CP; chronic phase; CR; complete remiss
Highly selective and efficient solvent-free transformation of bio-derived levulinic acid to γ-valerolactone by Ru(II) arene catalyst precursors
Keywords: GVL; γ-Valerolactone; LA; Levulinic acid; 4-HVA; 4-Hydroxyvaleric acid; Et3N; Triethylamine; FA; Formic acid; HMF; Hydroxymethylfurfural; Solvent-free reactions; Formic acid; Hydrogen generation; Levulinic acid; Gamma-valerolactone; Arene ruthenium(II) c
Fractionation of spent liquor from organosolv-pretreatment using lignin-incompatible extraction
Keywords: Organosolv pretreatment; Spent liquor; Lignin; GVL; Extraction;
Which factors influence the development of GVHD in HLA-matched or mismatched transplants?
Keywords: Allele; GVHD; Graft-versus-host disease; GVL; Graft versus leukemia; Hematopoietic cell transplantation; HCT; HLA; Matched; Mismatched;
Sub-clonal analysis of the murine C1498 acute myeloid leukaemia cell line reveals genomic and immunogenic diversity
Keywords: AML; acute myeloid leukaemia; CGH; comparative genomic hybridization arrays; CTL; cytotoxic T lymphocyte; qPCR; real time quantitative PCR; CR; complete remission; GvL; graft-versus-leukaemia; HSCT; haematopoietic stem cell transplantation; LICs; leukaemi
Harnessing the CD1 restricted T cell response for leukemia adoptive immunotherapy
Keywords: MHC; major histocompatibility complex; ACT; adoptive cell therapy; DC; Dendritic cells; AML; T-ALL. B-ALL; mLPA; methyl-lysophosphatidic acid; HSCT; hematopoietic stem cell transplantation; GVL; graft versus leukemia; GVHD; graft versus host disease; iNKT
One-pot lignin extraction and modification in γ-valerolactone from steam explosion pre-treated lignocellulosic biomass
Keywords: Green chemistry; Lignin extraction; γ-valerolactone; Chemical modification; Lignin-based material; SE; steam explosion; GVL; γ-valerolactone; MAE; microwave-assisted extraction; NREL; national renewable energy laboratory; WIS; water insoluble substrate;
Reaction mechanism of aqueous-phase conversion of γ-valerolactone (GVL) over a Ru/C catalyst
Keywords: γ-Valerolactone; GVL; Butanol; Pentanol; Pentanediol; Ring-opening; Hydrogenolysis; Hydrogenation; Decarbonylation; Ru/C catalyst; Bio-oil upgrading in aqueous phase;
Insights into the selective hydrogenation of levulinic acid to γ-valerolactone using supported mono- and bimetallic catalysts
Keywords: Levulinic acid conversion; Microwaves; Heterogeneous catalysis; GVL; Hydrogenation reactions
How important is NK alloreactivity and KIR in allogeneic transplantation?
Keywords: Acute myelogenous leukemia; Allogeneic hematopoietic cell transplantation; Allo HCT; Alloreactivity; AML; Graft versus host disease; GVHD; Graft versus leukemia; GVL; Killer Ig-like receptors; KIR; Natural killer; NK;
The in vitro generation of multi-tumor antigen-specific cytotoxic T cell clones: Candidates for leukemia adoptive immunotherapy following allogeneic stem cell transplantation
Keywords: AML; acute myeloid leukemia; ASCT; allogeneic stem cell transplantation; CFSE; carboxyfluorescein diacetate succinimidyl ester; FBS; fetal bovine serum; GVT; Graft-versus-tumor; GVHD; Graft-versus-host disease; GVL; graft-versus-leukemia; HAT; hypoxanthin
Ru nanoparticles supported graphene oxide catalyst for hydrogenation of bio-based levulinic acid to cyclic ethers
Keywords: Ru/graphene oxide; Levulinic acid; GVL; Hydrogenation
Small pore zeolite catalysts for furfural synthesis from xylose and switchgrass in a γ-valerolactone/water solvent
Keywords: Switchgrass; SAPO; Small-pore zeolites; Furfural; GVL;
Microkinetic analysis of ring opening and decarboxylation of γ-valerolactone over silica alumina
Keywords: γ-valerolactone; Microkinetic modeling; Solid acids; Decarboxylation; Ring opening; Biomass upgrading; GVL; γ-valerolactone; PEA; pentenoic acid; ASA; amorphous silica alumina; DPE; deprotonation energy; PA; proton affinity;
Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use
Keywords: 1,4-BD; 1,4-butanediol; AM; ante mortem; AMCD; Advisory Council on the Misuse of Drugs; BNF; British National Formulary; BZP; benzylpiperazine; Carboxy-THC; 11-nor-9-carboxy-delta-9-THC; CNS; central nervous system; CPP; 1-(3-chlorophenyl)piperazine hydro
Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients
Keywords: Hematopoietic stem cell transplant; H-Y minor histocompatibility antigen; CD8 T cell; CD137 assay; GVHD; GVL
The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation
Keywords: DFS; GvL; HLA-E polymorphisms; HSCT; Relapse;
A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia
Keywords: allo-HSCT; allogeneic hematopoietic stem cell transplantation; AML; acute myeloid leukemia; APC; allophycocyanin; CML; chronic myeloid leukemia; CFDA; 5,6-carboxyfluorescein diacetate succinimidyl ester; DLT; donor lymphocyte transfusions; ELISPOT; enzyme
Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells
Keywords: HSCT; hematopoietic stem cell transplantation; UCB; umbilical cord blood, UCBT, umbilical cord blood transplantation; UCBT; umbilical cord blood transplantation; GvHD; graft-versus-host disease; GvL; graft-versus-leukemia; DCs; dendritic cells; PDC; plasm
Influence of glutathione S-transferase T1 donor/recipient mismatch and anti-GSTT1 antibodies in hepatic graft-versus-host-disease
Keywords: mHags; minor histocompatibility antigens; HSCT; hematopoietic stem cell transplantation; GSTT1; glutathione S-transferase T1; GVHD; graft versus host disease; BAFF; B-cell activating factor; GVL; graft versus leukemia; RESITRA; Red Española para la Inves
Targeted immunotherapy for acute myeloid leukemia
Keywords: acute myeloid leukemia; AML; allogeneic; graft versus leukemia; GVL; hematopoietic stem cell transplantation; HSCT; interleukin-2; IL-2; killer immunoglobulin-like receptors; KIR; natural killer; NK; T cell
Translational studies in hematopoietic cell transplantation: Treatment of hematologic malignancies as a stepping stone to tolerance induction
Keywords: APC; antigen-presenting cell; ATG; anti-thymocyte globulin; ATS; anti-thymocyte serum; BMT; bone marrow transplantation; DLI; donor leukocyte infusion; GVHD; graft-versus-host disease; GVL; graft-versus-leukemia/lymphoma; GVT; graft-versus-tumor; HCT; hem
Pharmacologic Expansion of Donor-Derived, Naturally Occurring CD4+Foxp3+ Regulatory T Cells Reduces Acute Graft-versus-Host Disease Lethality Without Abrogating the Graft-versus-Leukemia Effect in Murine Models
Keywords: Treg cells; Bone marrow transplantation; Tolerance induction; GVHD; GVL
How closely related is graft-vs-leukemia to donor/recipient disparity?
Keywords: graft-vs-leukemia effect; GVL; graft-vs-host disease; GVHD; acute leukemia; human leukocyte antigen; HLA; mismatch; unrelated donor; cord blood; conditioning regimen
Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
Keywords: DLI; GVHD; GVL; Chimerism; MRD; Relapse
Mouse Models of Bone Marrow Transplantation
Keywords: Allogeneic; GVHD; GVL
Peptide prodrugs: Improved oral absorption of lopinavir, a HIV protease inhibitor
Keywords: Lopinavir; LVR; VL; VVL; GVL; Peptide; Prodrug
Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens
Keywords: B-ALL; B cell acute lymphoblastic leukemia; CEPH; Centre d'Etude Polymorphism Humain, CML, chronic myeloid leukemia; CTL; cytotoxic T lymphocyte; FCS; fetal calf serum; GVHD; graft-versus-host disease; GVL; graft-versus-leukemia; HS; human serum; IMDM; Is
Dendritic Cells in Transplantation and Immune-Based Therapies
Keywords: Dendritic cell; Transplantation; Allogeneic; Cell therapy; GVHD; GVL; GVT
Chronic Lymphocytic Leukemia: Diagnosis and Treatment
Keywords: AIHA; autoimmune hemolytic anemia; AML; acute myeloid leukemia; CALGB; Cancer and Leukemia Group B; CAP; cyclophosphamide, doxorubicin (Adriamycin), and prednisone; CHOP; cyclophosphamide, hydroxydaunomycin (doxorubicin), vincristine (Oncovin) and prednis
Lymphoproliferative disorders: prospects for gene therapy
Keywords: Gene therapy; lymphoproliferative disorders; lymphoma; Hodgkin; non-Hodgkin; immunotherapy; suicide gene; oncolytic virus; antisense; RNAi; AAV; adeno-associated virus; ALCL; anaplastic large cell lymphoma; CLL; chronic lymphocytic leukaemia; CTL; cytotox
Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases
Keywords: ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; ATG; anti-thymocyte globulin; BMT; bone marrow transplantation; CGD; chronic granulomatous disease; CML; chronic myeloid leukemia; CTL; cytotoxic T lymphocytes; CSA; cyclosporine A; DLI; dono
Minor Histocompatibility Antigens: Molecular targets for immunomodulation in tissue transplantation and tumor therapy
Keywords: mH-Ag; Minor antigen; GvHD; Graft versus Host Disease; Gvl; Graft-versus-Leukemia; MHC; Major Histocompatibility Complex; HLA; Human Leukocyte Antigen; APC; Antigen Presenting Cells; HSCT; Hematopoietic Stem Cell Transplant; BMT; Bone Marrow Transplant;
The influence of photodynamic therapy on the immune response
Keywords: 8-MOP; 8-methoxypsoralen; BCG; Bacillus Calmette-Guerin; ALA; 5-aminolevulinic acid; CD; cluster of differentiation; CHS; contact hypersensitivity; DBPMAF; Vitamin D3-binding protein-derived macrophage-activating factor; DC; dendritic cells; EAE; experime
Reduced-Intensity Allogeneic Stem Cell Transplantation in Adults and Children with Malignant and Nonmalignant Diseases: End of the Beginning and Future Challenges
Keywords: Reduced-intensity stem cell transplantation; Nonmyeloablative transplantation; GVL; GVHD;